Clinical Trial Update: Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a new formulation of acetylcysteine injection for acetaminophen overdose was terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acetaminophen Overdose

Drugs mentioned

• Acetylcysteine injection (new formulation) (N-acetylcysteine)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Acetaminophen Overdose | Phase 3 | Status: TERMINATED | Results posted: 2014-08-04